Mobile Health (mHealth) is a sub-segment of eHealth consisting mobile communication devices, such as mobile phones, tablet computers and PDAs, for health services and information exchange. mHealth applications include the use of mobile devices in collecting community and clinical health data, delivery of healthcare information to practitioners, researchers, and patients, real-time monitoring of patient vital signs, and direct provision of care (via mobile telemedicine). Mobile Health (mHealth) is most commonly used for the practice of clinical medicine and public health with the usage of mobile phones and tablets. Increasing incidences of chronic diseases and geriatric population, increase in the number of clinical trial groups, home care agencies and disease management companies are some of the factors that are driving the global mobile healthcare (mHealth) market.
The global mobile healthcare (mHealth) market report estimates the market size (Revenue US$ million – 2014 to 2021) and composition of this market based on device types (blood pressure, blood glucose, cardiac rhythm, pulse, sleep apnea, and multi-parameter monitors) and forecasts growth trends (CAGR% – 2017 to 2021).
The global mobile healthcare (mHealth) market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global mobile healthcare (mHealth) market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global mobile healthcare (mHealth) market and included in this report are AT&T, Inc., Bayer HealthCare AG, BioTelemetry, Inc. (CardioNet, Inc.), Boston Scientific Corporation, DexCom, Inc., Dräger AG, F. Hoffmann La-Roche Ltd., Johnson & Johnson, LifeWatch AG, Masimo Corporation, Medtronic, Inc. and Omron Healthcare.